New trends in immunoassays

Area of Science:

• Biotechnology
• Analytical Chemistry
• Medical Diagnostics

Background:

• Immunoassays are crucial for disease diagnosis, with growing demand for rapid, point-of-care (POC) testing due to chronic diseases and infectious outbreaks.
• Traditional immunoassays face limitations in sensitivity and speed, necessitating advanced technologies for improved diagnostic capabilities.
• The development of novel signal amplification strategies and next-generation lateral-flow assays is key to addressing these challenges.

Purpose of the Study:

• To explore innovative signal amplification technologies for immunoassays, focusing on enhancing sensitivity and detection limits.
• To review advancements in lateral-flow assay (LFA) technology, particularly those enabling point-of-care (POC) applications.
• To highlight how these technological improvements facilitate more efficient diagnosis and patient management.

Main Methods:

• Investigated novel signal amplification techniques, such as biofunctional nanocrystals (releasable fluorophores) and aggregation-induced emission (AIE).
• Examined bio-barcode assays utilizing magnetic beads and gold nanoparticle probes for analyte concentration and signal amplification.
• Reviewed new lateral-flow assay formats, including digital-style and immuno-threshold-based assays, and molecular compact discs for multiplexed detection.

Main Results:

• New amplification methods like AIE and nanocrystals significantly improve immunoassay sensitivity and lower detection limits.
• Bio-barcode assays demonstrate effective signal amplification through analyte concentration and oligonucleotide labeling.
• Advanced LFAs offer semi-quantitative or quantitative results at the point-of-care, simplifying interpretation and improving diagnostic efficiency.

Conclusions:

• Innovative signal amplification and lateral-flow assay technologies are revolutionizing immunoassays, enabling faster and more sensitive diagnostics.
• These advancements are crucial for the expansion of rapid, decentralized testing, particularly for managing chronic and infectious diseases.
• Future developments promise to bring diagnostic capabilities even closer to the patient, enhancing healthcare quality and enabling timely disease monitoring.